Concepedia

Michelle DeVeaux

MD

Statistics

Publications

10

Citations

274

H-Index

10

Active since

2020

Affiliations

Regeneron (United States)(Current)

Rutgers Cancer Institute

Indiana University – Purdue University Indianapolis

Columbia University Irving Medical Center

The Ohio State University

Michelle DeVeaux is an author at Regeneron (United States) specializing in quantitative pharmacology, medicine, and clinical trials.

Top concepts

Publications per year

2020–2023

10

Publications

10

Passive Prophylactic Administration with a Single Dose of Anti–Fel d 1 Monoclonal Antibodies REGN1908–1909 in Cat Allergen–induced Allergic Rhinitis: A Randomized, Double-Blind, Placebo-controlled Clinical Trial

Mohamed H. Shamji, Iesha Singh, Janice A. Layhadi et al. · American Journal of Respiratory and Critical Care Medicine · 2021 · 69 citations · Full text

LINKER-MM1 study: Linvoseltamab (REGN5458) in patients with relapsed/refractory multiple myeloma.

Hans C. Lee, Naresh Bumma, Joshua Richter et al. · Journal of Clinical Oncology · 2023 · 56 citations

, , +20

REGN1908/1909 prevented cat allergen–induced early asthmatic responses in an environmental exposure unit

Frederic J. de Blay, Alina Gherasim, Nathalie Domis et al. · Journal of Allergy and Clinical Immunology · 2022 · 38 citations · Full text

A therapeutic strategy to target distinct sources of IgE and durably reverse allergy

André Limnander, Navneet Kaur, Seblewongel Asrat et al. · Science Translational Medicine · 2023 · 22 citations

Daily Cannabis Users with Sickle Cell Disease Show Fewer Admissions than Others with Similar Pain Complaints

Susanna A. Curtis, Amanda M. Brandow, Michelle DeVeaux et al. · Cannabis and Cannabinoid Research · 2020 · 19 citations · Full text

1–5 of 10